Lyzalon (New Formulation)

01.30.2021

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LYZALON pregabalin Consumer Medicine Information What is […]

Arcoxia

01.30.2021

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ARCOXIA® Etoricoxib (pronounced ee-TOR-ee-cox-ib) Consumer Medicine Information […]

Caprelsa

01.30.2021

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CAPRELSA™ vandetanib Consumer Medicine Information What is […]

Avanza Tablets (MSD)

01.30.2021

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AVANZA® Mirtazapine 30mg Consumer Medicine Information What […]

Kevtam (new formula)

01.30.2021

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KEVTAM levetiracetam Consumer Medicine Information What is […]

Lorazepam Mylan

01.30.2021

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LORAZEPAM MYLAN Contains the active ingredient lorazepam […]

FDA Approves Klisyri

12.15.2020

FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp BUFFALO, N.Y., Dec. 15, 2020 […]